Enhabit (NYSE:EHAB) Sets New 12-Month High – Here’s What Happened

Enhabit, Inc. (NYSE:EHAB)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as $13.68 and last traded at $13.6650, with a volume of 656213 shares changing hands. The stock had previously closed at $13.66.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on EHAB shares. Wolfe Research set a $12.00 price target on Enhabit in a research note on Thursday, January 8th. Oppenheimer downgraded shares of Enhabit from an “outperform” rating to a “market perform” rating in a research note on Monday, February 23rd. TD Cowen reiterated a “hold” rating and set a $13.80 price objective (up from $12.00) on shares of Enhabit in a report on Friday, March 6th. Truist Financial set a $13.80 target price on shares of Enhabit in a research report on Monday, February 23rd. Finally, Citigroup restated a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Two research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $13.57.

Enhabit Price Performance

The company has a 50 day simple moving average of $12.20 and a 200 day simple moving average of $9.92. The company has a market capitalization of $692.62 million, a price-to-earnings ratio of -151.72 and a beta of 1.56. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76.

Enhabit (NYSE:EHAB) last issued its earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.14. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%.The business had revenue of $270.40 million during the quarter, compared to analysts’ expectations of $270.56 million. As a group, research analysts predict that Enhabit, Inc. will post 0.22 EPS for the current year.

Insider Activity at Enhabit

In other news, EVP Julie Diane Jolley sold 2,793 shares of the firm’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $13.63, for a total value of $38,068.59. Following the transaction, the executive vice president owned 139,923 shares of the company’s stock, valued at approximately $1,907,150.49. This trade represents a 1.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 3.40% of the company’s stock.

Institutional Trading of Enhabit

Several large investors have recently added to or reduced their stakes in EHAB. Bailard Inc. acquired a new stake in shares of Enhabit in the third quarter valued at about $442,000. Segall Bryant & Hamill LLC purchased a new position in Enhabit in the 3rd quarter worth approximately $1,926,000. Globeflex Capital L P acquired a new stake in Enhabit in the second quarter valued at approximately $1,154,000. Y Intercept Hong Kong Ltd grew its position in Enhabit by 188.2% in the third quarter. Y Intercept Hong Kong Ltd now owns 218,284 shares of the company’s stock valued at $1,748,000 after acquiring an additional 142,556 shares in the last quarter. Finally, 8 Knots Management LLC raised its stake in shares of Enhabit by 9.5% during the third quarter. 8 Knots Management LLC now owns 4,218,846 shares of the company’s stock valued at $33,793,000 after purchasing an additional 365,779 shares during the period.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.